Major Histocompatibility Complex Genes as Therapeutic Opportunity for Immune Cold Molecular Cancer Subtypes
Current immunotherapies are effective only in a subset of patients, likely due to several factors including defects in tumor cell antigen presentation, decreased response to immune effectors, and molecular heterogeneity of cancers. Recent molecular classifications enable the categorization of many t...
Saved in:
Main Authors: | Paweł Karpiński, Łukasz Łaczmański, Maria M. Sąsiadek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/8758090 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Geometry Dynamics of α-Helices in Different Class I Major Histocompatibility Complexes
by: Reiner Ribarics, et al.
Published: (2015-01-01) -
Association of Major Histocompatibility Complex Polymorphism With Acute Phase Response in Broiler Chicken
by: Afra Vatankhah, et al.
Published: (2024-11-01) -
Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection
by: Ankit Bharat, et al.
Published: (2017-01-01) -
Hypoxemic Bronchiolitis Related to Major Histocompatibility Class II Deficiency
by: S. Hammami, et al.
Published: (2013-01-01) -
Immunopathogenesis of spondyloarthropathies – Concept of major histocompatibility locus-I-opathy
by: Amlan Kusum Datta, et al.
Published: (2021-01-01)